2024

LinusBio Wins 2024 BioTech Breakthrough Award for “Overall MedTech Company of the Year”

Read more
2022

Novozymes and LinusBio announce collaboration to accelerate scientific discovery in Biohealth

LinusBio Recognized at the 2022 Mount Sinai Innovation Awards

2022

WATCH: Detecting Autism at Birth and Opportunity for Early Intervention

2021

Linus Biotechnology Inc. Receives FDA Breakthrough Device Designation for StrandDx™-ASD Exposome Sequencing Diagnostic

2021

Mount Sinai Spin-Off Linus Biotechnology Inc. to Revolutionize Precision Medicine with Exposome Sequencing